Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
Globe Newswire (Thu, 10-Sep 9:00 AM ET)
Globe Newswire (Wed, 9-Sep 9:01 AM ET)
Omada Health’s Record Revenue and Member Growth Signal Strategic Momentum Ahead of CEO Transition
Market Chameleon (Fri, 7-Aug 7:25 AM ET)
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition
Globe Newswire (Thu, 6-Aug 4:03 PM ET)
Globe Newswire (Thu, 23-Jul 11:27 AM ET)
Globe Newswire (Thu, 23-Jul 9:00 AM ET)
Omada Health to Host its First Investor Day on September 10, 2026
Globe Newswire (Wed, 15-Jul 9:00 AM ET)
Omada Health to Participate in Canaccord Genuity's 46th Annual Growth Conference
Globe Newswire (Mon, 13-Jul 9:00 AM ET)
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Omada Health trades on the NASDAQ stock market under the symbol OMDA.
As of October 9, 2026, OMDA stock price climbed to $21.48 with 309,210 million shares trading.
OMDA has a beta of 1.72, meaning it tends to be more sensitive to market movements. OMDA has a correlation of 0.10 to the broad based SPY ETF.
OMDA has a market cap of $1.31 billion. This is considered a Small Cap stock.
Last quarter Omada Health reported $88 million in Revenue and $.08 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.02.
The top ETF exchange traded funds that OMDA belongs to (by Net Assets): VTI, IWM, IWO, FYC, SCHA.
OMDA has underperformed the market in the last year with a return of -10.4%, while the SPY ETF gained +16.9%. In the last 3 month period, OMDA fell short of the market, returning -6.5%, while SPY returned +4.8%. However, in the most recent 2 weeks OMDA has outperformed the stock market by returning +8.9%, while SPY returned +1.5%.
OMDA support price is $20.13 and resistance is $21.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMDA shares will trade within this expected range on the day.